China Pharma Holdings (CPHI) Change in Cash (2010 - 2026)

China Pharma Holdings (CPHI) has reported Change in Cash for 17 consecutive years, with $136400.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Cash fell 35.76% year-over-year to $136400.0; the trailing twelve-month figure through Jun 2026 stood at -$320158.0 (down 180.09% YoY), and the FY2025 full-year result was -$281767.0, up 64.64% from the prior year.
• Change in Cash grew to $136400.0 in Q2 2026 per CPHI's latest filing, from -$176638.0 in the prior quarter.
• Across five years, Change in Cash topped out at $467961.0 in Q3 2023 and bottomed at -$1.5 million in Q2 2022.
• Historically, Change in Cash has averaged -$253010.3 across 5 years, with a median of -$129104.0 in 2022.
• The sharpest annual moves came in 2023 and 2025: Change in Cash jumped 394.94% in 2023, then plunged 1631.12% in 2025.
• Over 5 years, Change in Cash stood at -$56327.0 in 2022, then jumped by 195.81% to $53967.0 in 2023, then tumbled by 270.13% to -$91812.0 in 2024, then soared by 184.4% to $77487.0 in 2025, then soared by 76.03% to $136400.0 in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered $136400.0, -$176638.0, and $77487.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.